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Abstract
Introduction: Bacillus Calmette-Guérin (BCG) is an attenuated strain of Mycobacterium bovis.
Usually, systemic complications due to BCG vaccination are quite rare. However, since BCG is a
live vaccine, there is still a possibility that it may cause an infection.
Case presentation: Hepatic granuloma was found incidentally in an asymptomatic 5-month-old
infant who was found dead in his bed. The probable cause of death was asphyxia due to milk
aspiration into the lungs. The granuloma was composed of epithelioid histiocytes with frequent
multinucleated Langhans-type giant cells and a small number of lymphocytes.
Conclusion: The cause of the asymptomatic granuloma was not identified, but was considered
likely due to BCG vaccination.
Introduction
Bacillus Calmette-Guérin (BCG) is an attenuated strain of
Mycobacterium bovis (e.g., Tokyo172 strain), which is still
widely used as a vaccine (immunogen) against M. tubercu-
losis infections and is a potent immunomodulator. Usu-
ally, BCG vaccination causes only localized and weak skin
irritation around the inoculation spots, and systemic
complications are quite rare. However, since BCG is a live
vaccine, there is still a possibility that it may cause an
infection. Dissemination is a rare but well-known compli-
cation of BCG vaccination. It occurs principally in immu-
nodeficient patients, and skin, bone, and visceral organs
are sometimes affected. Less frequently, disseminated
BCG infection has also been described in apparently nor-
mal (immunocompetent) patients [1,2]. Most previously
reported cases have been in patients with bladder cancer
who have undergone immunotherapy with BCG (intra-
vesical installation) [3-8].
Here we report an infant in whom an asymptomatic
hepatic granuloma was found incidentally at autopsy.
Case presentation
A 5-month-old male infant (height 68 cm, weight 5.8 kg)
was found dead in his bed. Further information concern-
ing this event was not available. He had been born at full
term of pregnancy (38 weeks) with a birth weight of 2.6
kg. His growth and development had been normal, and
his parents were not aware of any physical abnormality.
His body temperature and appetite had been normal until
his death, and there were no relevant signs or symptoms.
The infant had died after normal breastfeeding and being
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left to sleep. When his mother checked how he was, she
found him dead in a prone posture on the bed. The bed-
clothes were soiled by a white and soft coagulated mate-
rial, suggesting that the infant had vomited milk. He had
been vaccinated with BCG 2 months before death. His
family members all gave a normal tuberculin reaction,
and there was no evidence that any of them suffered from
active tuberculosis.
Pathological findings
A complete autopsy was performed 26 h after the infant's
death. Besides routine hematoxylin and eosin (H&E)-
stained sections, additional sections were used for acid-
fast bacilli staining and DNA extraction [9]. Polymerase
chain reaction (PCR) for mycobacterium detection
(Amplicor; Roche Diagnostics; Basel, Switzerland) was
performed in accordance with the manufacturer's techni-
cal insert (lower detection limit = ~5 DNA copies/sample)
[10].
Macroscopic examination revealed almost no visible
abnormalities in any of the organs. Localized, small areas
of weak skin irritation with scabs were around the BCG
inoculation spots on the left arm.
Microscopic examination (Fig. 1) revealed that a number
of bronchioli and alveolar ducts were obstructed with
uneven eosinophilic material containing oral epithelium
with bacterial growth, bile components, alveolar macro-
phages, and massive bronchial epithelia (including basal
cells). As far as could be observed, most of the bronchial
epithelium had peeled off with slight bleeding in the sub-
mucosal layers.
Interestingly, liver tissue sections (Fig. 2) contained a
number of microscopic granulomas (~10 per section),
although no similar lesions were found in other organs,
and otherwise the liver revealed no additional pathologi-
cal changes. The granulomas found in the liver (Fig. 3)
were composed of epithelioid histiocytes with frequent
multinucleated Langhans-type giant cells and a small
number of lymphocytes. All the granulomas were round
in shape, clearly delimited, and well organized. No evi-
dence of necrosis was found at the center of each granu-
loma, and an extensive inspection showed that none of
the granulomas contained acid-fast bacilli or fungi. Sensi-
tive PCR analyses performed on DNA extracts from paraf-
fin sections were all negative for mycobacterium. In
addition, we checked several similar cases submitted for
autopsy (i.e., infant sudden death after BCG vaccination),
but no such granulomatous lesions were found.
Discussion
Microscopic observation revealed that most of the epithe-
lium in the respiratory tract had peeled off with submu-
cosal bleeding. Usually, such findings are observed in
patients who have received artificial ventilarory support,
but this infant had not been resuscitated. Considering that
milk aspiration (stomach contents) had probably
occurred in the lungs, one possible interpretation of this
finding is that the infant had exhibited strong labored
breathing (or coughing) for a while to expel the aspirated
liquid. Therefore, we considered that the cause of death
had probably been asphyxia rather than sudden infant
death syndrome (SIDS).
Pathological findings in the lungs Figure 1
Pathological findings in the lungs. A number of bronchi-
oli and alveolar ducts were obstructed with uneven eosi-
nophilic material containing oral epithelium, alveolar 
macrophages, and massive bronchial epithelia (H&E, × 100).
Pathological findings in the liver Figure 2
Pathological findings in the liver. Granulomas were 
found with no additional pathological changes (H&E, × 50).Cases Journal 2008, 1:337 http://www.casesjournal.com/content/1/1/337
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The presence of epithelioid cell granuloma in the liver
usually indicates a diagnosis of disseminated BCG infec-
tion (miliary BCG) or classical miliary tuberculosis. The
latter was ruled out, however, because of the absence of
tuberculous lesions in other organs (e.g., lungs, mediasti-
nal lymph nodes, spleen, and meninges). In addition, the
absence of acid-fast bacilli in histological sections associ-
ated with the negative mycobacterial PCR result indicated
that this was not active infection due to mycobacterium.
The possibility of sarcoidosis is rather remote in such a
young infant [11], and there was no evidence suggesting
this disease in the lungs. The absence of any additional
pathological changes in the liver ruled out neonatal (giant
cell-type) hepatitis and biliary tract diseases. Therefore, we
considered that the hepatic granuloma had been induced
by BCG vaccination.
Vaccination with BCG is obligatory for newborns in
Japan, the first dose usually being given at 3~6 month of
age. Although many reliable studies have demonstrated
its beneficial effects and safety [12], BCG vaccination is
not always without complications (Table 1) [13]. For
example, a recent report has estimated the prevalence rate
of symptomatic disseminated BCG to be below one per
106 vaccinations [14].
As is the case with most infectious diseases, the host
immunity seems to play an important role in the develop-
ment of such complications. Disseminated infection is
known to be one of the most serious complications of
BCG vaccination, and occurs principally in immunocom-
promised hosts [1,15-17]. In such cases, a number of
inflammatory lesions (e.g., epithelioid cell granulomas)
develop systemically (mainly in the lungs and liver).
These granulomas are characterized by extensive tissue
necrosis, poor structural formation, and extensive collec-
tions of histiocytes and epithelioid cells with abundant
acid-fast bacilli, and only a few giant cells. The outcome is
usually fatal, and autopsy reveals many visible lesions in
almost every organ [1].
In Japan, there have been only two fatalities attributed to
BCG vaccination, and both of the affected individuals
were found to have immunodeficiency. The BCG strain
used in Japan (Tokyo172 strain) is known to be highly
safe for immunocompetent hosts. In healthy animals,
BCG inoculation sometimes (frequently at a high dose
vaccination dose) induces the formation of epithelioid
cell granulomas (especially in the liver and spleen) [18],
but most of them are only transient: i.e., they will usually
resolve without anti-mycobacterial chemotherapy (manu-
facturer's personal communication).
In immunocompetent humans, most BCG complications
(if present) are local and/or regional (Table 1). However,
disseminated BCG infection does occur rarely in appar-
ently immunocompetent infants and children [19-24].
These patients show a well-developed granulomatous
response with few (or no) bacilli inside the lesions, and
Pathological appearance of the liver granulomas Figure 3
Pathological appearance of the liver granulomas. The 
granulomas were composed of epithelioid histiocytes with 
frequent multinucleated Langhans-type giant cells and a small 
number of lymphocytes. All granulomas were round in shape, 
clearly delimited, and well organized with no caseous necro-
sis (H&E, × 200).
Table 1: Known complications of BCG vaccination
Local
Skin ulceration




Miliary granuloma (mainly lungs and liver)
Osteomyelitis
Immunocompromised
Severe systemic dissemination (with poorly formed granulomas and numerous bacilli)Cases Journal 2008, 1:337 http://www.casesjournal.com/content/1/1/337
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their clinical outcomes are generally good. Our experience
in the present case was rather similar, and therefore we
considered that the hepatic granuloma had been due to
transient and subtle BCG infection. Historically, Gormsen
has also reported granulomas in forensic autopsy cases
(i.e., patients who had died due to unexpected causes such
as trauma) [25]. According to his report, definite evidence
of granuloma was not found in any organ later than 40
months after vaccination. In 13 of the 20 cases studied
from 6 weeks to 40 months after BCG vaccination, granu-
lomas were demonstrated in the liver (n = 10), lung (n =
6), peribronchial lymph nodes (n = 2), spleen (n = 2), and
kidney (n = 2), but acid-fast bacilli were detected only in
the regional lymph nodes near the vaccination site (not in
other organs). In 11 cases the number of granulomas was
small, whereas they were numerous in the other two
which were low-weight infants of less than 1 year of age
[25].
It has been demonstrated that BCG can be highly patho-
genic to specific individuals for unknown reasons [9,20].
Since clinically symptomatic BCG dissemination has
recently been interpreted as always resulting from an
underlying immunodisorder (although this seemed to be
clear in only 50% of the cases reviewed [2]), miliary BCG
dissemination might result from a very subtle (yet
unknown) form of immunodeficiency. For example, it
has been noted that a deficiency or mutation of the inter-
feron-γ receptor 1 gene seems to increase susceptibility to
mycobacterial infections [26]. In addition, the BCG strain
used in Japan (Tokyo172 strain) is known to be very
quickly killed in lysosomes after phagocytosis, which is
the main reason for its high safety, and therefore, the clin-
ical dose used in BCG vaccination usually causes almost
no pathological changes (manufacturer's personal com-
munication). Considering this information, the present
infant might have had a defect in the phagocytosis and/or
killing of the BCG. 
Table 2 lists 5 representative cases in which the outcome
was fatal, taken from the recent literature for comparison
(the present case is Case 6 in the table). Most of the cases
involved miliary granulomas mainly in the lungs and
liver. However, these lesions may even represent a natural
immunoresponse to the vaccine [25], which is further
supported by findings that similar dissemination occurred
after intravesical BCG installation [3-8]. The alternative
possibility is that this infant died due to an unrelated con-
dition (e.g., SIDS or asphyxia), with the granulomatous
process representing a subtle pattern of BCG dissemina-
tion that might occur more commonly than is usually
realized. In this sense, the present case may be a good
example supporting this hypothesis.
The present case also raises two important questions
regarding clinical pathology. One is whether the presence
of epithelioid cell granulomas in the liver always indicates
miliary tuberculosis. The answer is certainly "No"; the
present infant had asymptomatic hepatic granuloma that
was probably caused by BCG vaccination. The other one
is why the granulomas formed only in the liver. Although
we cannot answer this question, two possibilities can be
considered: (1) BCG bacilli disseminated from the inocu-
lation site, and reached organs showing affinity for this
pathogen (such as the liver and spleen). Finally, the bacilli
were phagocytosed by residual phagocytes. (2) BCG
bacilli were phagocytosed at the inoculation site, and the
phagocytes (macrophages) carrying the bacilli circulated
throughout the whole body and reached a hub site for
immunosurveillance (such as the liver), where they finally
formed granulomas. In any event, it is well known that the
liver is involved in many infectious diseases.
Conclusion
The cause of the asymptomatic granulomas in this case
was not identified, but BCG vaccination was considered
the most likely.
Abbreviations
BCG: bacillus Calmette-Guérin; GE: gastro-esophageal;
H&E: hematoxylin and eosin; PCR: polymerase chain
reaction; SIDS: sudden infant death syndrome.
Table 2: Six infants having granulomas found at autopsy
Case Age (month) Clinical situation Autopsy findings
Miliary granuloma
1 3 Sudden death + (lungs)
2* 2 Apneic bronchiolitis, GE reflux + (lungs), Acute superficial colitis
3* 2 Diarrhea, Seizures, Severe dehydration + (lungs and liver)
4* 5 Sudden death + (lungs, liver, and thyroid)
5 5 Chicken pox (found dead) + (lungs, liver, and kidneys)
6 5 GE reflux (found dead) - (only liver granuloma)
Adapted from Ref.9. *PCR was positive for mycobacterium. The present case is Case 6.
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